dNLR at the baseline (B), defined by neutrophils/[leucocytes-neutrophils], correlates with immune-checkpoint inhibitor (ICI) outcomes in advanced non-small-cell lung cancer (aNSCLC). However, dNLR is dynamic under therapy and its longitudinal assessment may provide data predicting efficacy. We sought to examine the impact of dNLR dynamics on ICI efficacy and understand its biological significance.
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics
Carnio, Simona;Bironzo, Paolo;Tabbò, Fabrizio;Reale, Maria Lucia;Novello, Silvia;Mariniello, AnnaPaola;
2021-01-01
Abstract
dNLR at the baseline (B), defined by neutrophils/[leucocytes-neutrophils], correlates with immune-checkpoint inhibitor (ICI) outcomes in advanced non-small-cell lung cancer (aNSCLC). However, dNLR is dynamic under therapy and its longitudinal assessment may provide data predicting efficacy. We sought to examine the impact of dNLR dynamics on ICI efficacy and understand its biological significance.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
984.9 kB
Formato
Adobe PDF
|
984.9 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
